Kinetic studies on the oxidation of oxyhemoglobin by biologically active iron thiosemicarbazone complexes: relevance to iron-chelator-induced methemoglobinemia

A DFT and TD-DFT Approach to the Understanding of Statistical Kinetics in Substitution Reactions of M3Q4 (M=Mo, W; Q=S, Se) Cuboidal Clusters

(2012) Andrés G. Algarra et al.   CHEMISTRY-A EUROPEAN JOURNAL

Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia

(2012) Charles A Kunos et al.   Future Oncology

Water-Soluble Mo3S4 Clusters Bearing Hydroxypropyl Diphosphine Ligands: Synthesis, Crystal Structure, Aqueous Speciation, and Kinetics of Substitution Reactions

(2012) Manuel G. Basallote et al.   INORGANIC CHEMISTRY

Biologically active thiosemicarbazone Fe chelators and their reactions with ferrioxamine B and ferric EDTA; a kinetic study

(2011) Paul V. Bernhardt et al.   DALTON TRANSACTIONS

Copper(II) Complexes of a Hexadentate Mixed-Donor N3S3Macrobicyclic Cage: Facile Rearrangements and Interconversions

(2010) Craig A. Bell et al.   CHEMISTRY-A EUROPEAN JOURNAL

Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) for Locally Advanced Cervical Cancer

(2010) C. A. Kunos et al.   CLINICAL CANCER RESEARCH

Outer-Sphere Redox Reactions Leading to the Formation of Discrete CoIII/FeIIPyrazine-Bridged Mixed-Valence Compounds

(2009) Paul V. Bernhardt et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503

(2009) Anne M. Traynor et al.   INVESTIGATIONAL NEW DRUGS

Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors

(2009) Yu Yu et al.   JOURNAL OF MEDICINAL CHEMISTRY

Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia

(2008) Olatoyosi M. Odenike et al.   INVESTIGATIONAL NEW DRUGS

A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas

(2008) Steven Attia et al.   INVESTIGATIONAL NEW DRUGS

Iron Chelators of the Dipyridylketone Thiosemicarbazone Class: Precomplexation and Transmetalation Effects on Anticancer Activity

(2008) Paul V. Bernhardt et al.   JOURNAL OF MEDICINAL CHEMISTRY